We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
B-North intends to revolutionise the business lending industry, which is often outdated, impersonal and slow. The fintech company uses some of the most advanced cloud-based technology, coupled with face-to-face relationship teams to get the best lending solutions for borrowers and their businesses. The company is powered by a team with prior experience in starting and scaling challenger banks, and profitability is its focused goal. B-North has submitted the banking licence application, and the result is expected by 2020.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £2,135,456
 luxury British distillery to create high quality spirits using innovative and natural ingredients. Over the past three years, sales have increased 45% each year.
days to go: Expired investment: £554,074
Taster is a collection of online restaurants dedicated to bringing the best street food to users. The company says that it has launched five highly successful digital restaurant brands with chefs and food personalities, is available in 11 cities across the UK, France and Spain, and has onboarded over 20 partners. Taster's revenue grew 110% to €10.5 million in 2020 alone where it delivered over 1 million meals. The company has raised $50 million to date from investors such as Battery Ventures, Octopus Ventures Rakuten, LocalGlobe (Latitude) and Heartcore Capital. It claims that Taster brands hold the third-largest market share on Deliveroo in Paris. It will use the investment to increase Taster’s presence across the UK, France and Spain, drive expansion into new cities, support the launch of two new consumer brands in 2021, and take the company globally by signing up with more through more restaurants brands.
days to go: Expired investment: £592,079
PRESS is a health food and nutrition business specialising in Cold-Pressed juices, snacks, smoothies, soups and supplements.Our products bring healthy, delicious recipes to the hands of those customers looking to make positive decisions when it comes to what, when and how they eat and drink
days to go: Expired investment: £1,114,540
Super Snaps is a photo printing service designed for the fast-growing millennial audience. Super Snaps has become a proven brand and model as its team has printed more than 2,000,000+ photos since its launch. The company has more than 40,000 customers who have given it a +5 star Trustpilot rating. In 2018, Super Snaps became the official reseller for Polaroid. Furthermore, Super Snaps is planning to incorporate international expansion and innovative functionality. With its proceeds, the company aims to inaugurate seven new product lines by generating new revenue streams and growing market share.
days to go: Expired investment: £43,950
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph